ArticleTherapeutic advances in medical oncology2025
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study.
Fumihiko Kinoshita et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.